Optimizing HIV Care for an Aging Population

Release date: September 30, 2018

Expiration date: September 30, 2019

Estimated time to complete activity: 1.25 hours

This activity is jointly provided by the Postgraduate Institute for Medicine and the American Academy of HIV Medicine.

Target Audience
This activity has been designed to meet the educational needs of physicians, physician assistants, nurse practitioners, and pharmacists; this activity is also designed for healthcare professionals who treat or manage patients with HIV such as registered nurses, nutritionists, social workers, case managers, as well as case workers and secondary service providers who work in non-medical fields of care of patients with HIV.

Educational Objectives
After completing this activity, the participant should be better able to:
  • Develop appropriate treatment regimens and management strategies for managing older patients with HIV taking into account the effects of aging and co-morbid conditions.
  • Select ART regimens that balance the control of virus with the potential for long-term side effects, particularly in older patients and those on antiviral therapy over many years.
  • Review the psychosocial challenges of aging with HIV
  • Manage co-infections, co-morbidities and opportunistic infections, particularly those chronic conditions common to the aging population at large.

Keynote Speaker:
Meredith Greene, MD, AAHIVS
Medical Director, UCSF Home Health & Care at Home
Associate Director, Golden Compass Program in HIV and Aging
Division of Geriatrics
Assistant Professor of Medicine
University of California San Francisco

Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and the American Academy of HIV Medicine.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.25 contact hour(s) (0.125 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number – JA4008162-9999-18-376-H01-P)
Type of Activity: Knowledge

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty, Meredith Greene, MD, AAHIVS has nothing to disclose.

The PIM planners and managers have nothing to disclose. The AAHIVM planners and managers have nothing to disclose.

Method of Participation and Request for Credit:
There are no fees for participating and receiving CME/CE credit for this activity. During the period September 30, 2018 through September 30, 2019 participants must read the learning objectives and faculty disclosures and study the educational activity.

If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation on www.cmeuniversity.com. On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by course ID 13832. Upon registering and successfully completing the post-test with a score of 75% or better and the activity evaluation, your certificate will be made available immediately.

For Pharmacists: Upon successfully completing the post-test with a score of 75% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.

Type of activity: Internet

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.